References
1 World Health Organization/Diabetes
2 National Diabetes Statistics Report 2022
3 American Diabetes Association, “Economic Costs of Diabetes in the US in 2017,” Diabetes Care 2018;41(5): 917 – 928
4 Duca FA, Waise TMZ, Peppler WT, Lam TKT. The metabolic impact of small intestinal nutrient sensing. Nature Communications. 2021;12(1):903.
5 Blouet C, Schwartz GJ. Duodenal Lipid Sensing Activates Vagal Afferents to Regulate Non-Shivering Brown Fat Thermogenesis in Rats. PLOS ONE. 2012;7(12):e51898.
6 Saydah SH. Medication Use and Self-Care Practices in Persons With Diabetes. In: Cowie CC, Casagrande SS, Menke A, et al., editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 39.
7 Riddle et al. Standards of Diabetes Care. 2022; 45, Suppl 1
8 Verdam FJ, Greve JWM, Roosta S, et al. Small Intestinal Alterations in Severely Obese Hyperglycemic Subjects. J Clin Endocrinol Metab. 2011;96(February):379-383. doi:10.1210/jc.2010-1333
9 Theodorakis MJ, Carlson O, Michopoulos S, et al. Human duodenal enteroendocrine cells : source of both incretin peptides , GLP-1 and GIP. Am J Physiol Endocrinol Metab. 2006;290:E550-E559. doi:10.1152/ajpendo.00326.2004.